Patents by Inventor Wei-Ching Liang

Wei-Ching Liang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of reducing blood glucose by administering RON agonists
    Patent number: 10005848
    Abstract: This invention relates to RON compositions, in particular RON composition comprising a RON agonist, and methods of using the compositions for the treatment of diseases. The invention also relates to diagnosis of RON-associated or MSP-associated diseases.
    Type: Grant
    Filed: May 29, 2015
    Date of Patent: June 26, 2018
    Assignee: GENENTECH, INC.
    Inventors: Jackson G Egen, Jo-Anne Hongo, Steven Kauder, Robert A Lazarus, Lydia Santell, Yan Wu, Meredith Hazen, Wei-Ching Liang
  • Anti-CD33 antibodies and immunoconjugates
    Patent number: 9951133
    Abstract: The invention provides anti-CD33 antibodies and immunoconjugates and methods of using the same.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: April 24, 2018
    Assignee: GENENTECH, INC.
    Inventors: Shang-Fan Yu, Wei-Ching Liang, Yan Wu, Steven Leong, Andrew Polson
  • ANTI-CLL-1 ANTIBODIES AND IMMUNOCONJUGATES
    Publication number: 20180044420
    Abstract: The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: July 24, 2017
    Publication date: February 15, 2018
    Applicant: Genentech, Inc.
    Inventors: Bing Zheng, Andrew Polson, Cecilia Chiu, Wei-Ching Liang, Yan Wu
  • ANTI-CLL-1 ANTIBODIES AND IMMUNOCONJUGATES
    Publication number: 20180044421
    Abstract: The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: July 24, 2017
    Publication date: February 15, 2018
    Applicant: Genentech, Inc.
    Inventors: Bing Zheng, Andrew Polson, Cecilia Chiu, Wei-Ching Liang, Yan Wu
  • ANTI-CLL-1 ANTIBODIES AND IMMUNOCONJUGATES
    Publication number: 20180009894
    Abstract: The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: July 24, 2017
    Publication date: January 11, 2018
    Applicant: Genentech, Inc.
    Inventors: Bing Zheng, Andrew Polson, Cecilia Chiu, Wei-Ching Liang, Yan Wu
  • ANTI-HtrA1 ANTIBODIES AND METHODS OF USE
    Publication number: 20170342163
    Abstract: The invention provides anti-HtrA1 antibodies and methods of using the same.
    Type: Application
    Filed: July 18, 2017
    Publication date: November 30, 2017
    Inventors: Yan WU, Menno van LOOKEREN CAMPAGNE, Daniel KIRCHHOFER, Michael Terry LIPARI, Kenneth J. KATSCHKE, Jr., Paul M. MORAN, Scott STAWICKI, Wei-Ching LIANG
  • Anti-CLL-1 antibodies and immunoconjugates
    Patent number: 9751946
    Abstract: The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: September 5, 2017
    Assignee: Genentech, Inc.
    Inventors: Bing Zheng, Andrew Polson, Cecilia Chiu, Wei-Ching Liang, Yan Wu
  • ANTI-B7-H4 ANTIBODIES AND IMMUNOCONJUGATES
    Publication number: 20170239366
    Abstract: The invention provides anti-B7-H4 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: December 21, 2016
    Publication date: August 24, 2017
    Applicant: Genentech, Inc.
    Inventors: Steven R. LEONG, Andrew POLSON, Paul POLAKIS, Yan WU, Wei-Ching LIANG, Ron FIRESTEIN
  • Anti-HtrA1 antibodies and methods of use
    Patent number: 9738727
    Abstract: The invention provides anti-HtrA1 antibodies and methods of using the same.
    Type: Grant
    Filed: October 12, 2012
    Date of Patent: August 22, 2017
    Assignee: Genentech, Inc.
    Inventors: Yan Wu, Menno van Lookeren-Campagne, Daniel Kirchhofer, Michael Terry Lipari, Kenneth J. Katschke, Jr., Paul M. Moran, Scott Stawicki, Wei-Ching Liang
  • Anti-TAT226 antibodies and immunoconjugates
    Patent number: 9675707
    Abstract: Anti-TAT226 antibodies and immunoconjugates thereof are provided. Methods of using anti-TAT226 antibodies and immunoconjugates thereof are provided.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: June 13, 2017
    Assignee: Genentech, Inc.
    Inventors: Wei-Ching Liang, Chie Sakanaka, Yan Wu
  • ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20170145113
    Abstract: The present invention provides anti-HtrA1 antibodies (including bispecific anti-HtrA1 anti-Factor D antibodies) and methods of making and using the same, for example, in methods of treating HtrA1-associated disorders, ocular disorders, and/or complement-associated disorders.
    Type: Application
    Filed: October 27, 2016
    Publication date: May 25, 2017
    Inventors: Robert F. KELLEY, Daniel K. KIRCHHOFER, Joyce LAI, Chingwei V. LEE, Wei-Ching LIANG, Michael T. LIPARI, Kelly M. LOYET, Tao SAI, Menno VAN LOOKEREN CAMPAGNE, Yan WU, Germaine FUH
  • ANTI-TIGIT ANTIBODIES AND METHODS OF USE
    Publication number: 20170088613
    Abstract: The invention provides anti-TIGIT (T-cell immunoreceptor with Ig and ITIM domains) antibodies and methods of using the same.
    Type: Application
    Filed: September 23, 2016
    Publication date: March 30, 2017
    Inventors: Jane L. GROGAN, Robert J. JOHNSTON, Yan WU, Wei-Ching LIANG, Patrick LUPARDUS, Mahesh YADAV, Dhaya SESHASAYEE, Meredith HAZEN
  • ANTI-VEGF ANTIBODIES
    Publication number: 20170073405
    Abstract: Anti-VEGF antibodies and variants thereof, including those having high affinity for binding to VEGF, are disclosed. Also provided are methods of using phage display technology with naïve libraries to generate and select the anti-VEGF antibodies with desired binding and other biological activities. Further contemplated are uses of the antibodies in research, diagnostic and therapeutic applications.
    Type: Application
    Filed: April 25, 2016
    Publication date: March 16, 2017
    Inventors: Germaine FUH, Hans-Peter GERBER, Wei-Ching LIANG, Frederic FELLOUSE, Sachdev S. SIDHU, Christian WIESMANN
  • Anti-B7-H4 antibodies and immunoconjugates
    Patent number: 9562099
    Abstract: The invention provides anti-B7-H4 antibodies and immunoconjugates and methods of using the same.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: February 7, 2017
    Assignee: Genentech, Inc.
    Inventors: Steven R. Leong, Andrew Polson, Paul Polakis, Yan Wu, Wei-Ching Liang, Ron Firestein
  • ANTI-CD33 ANTIBODIES AND IMMUNOCONJUGATES
    Publication number: 20170002074
    Abstract: The invention provides anti-CD33 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: June 2, 2016
    Publication date: January 5, 2017
    Applicant: GENENTECH, INC.
    Inventors: Shang-Fan Yu, Wei-Ching Liang, Yan Wu, Steven Leong, Andrew Polson
  • ANTI-CLL-1 ANTIBODIES AND METHODS OF USE
    Publication number: 20160368994
    Abstract: The present invention relates to anti-CLL-1 antibodies including anti-CLL-1 antibodies comprising a CLL-1 binding domain and a CD3 binding domain (e.g., anti-CLL-1/CD3 T cell dependent bispecific (TDB) antibody) and methods of using the same.
    Type: Application
    Filed: June 14, 2016
    Publication date: December 22, 2016
    Applicant: Genentech, Inc.
    Inventors: Robert F. Kelley, Steven R. Leong, Wei-Ching Liang, Mary Mathieu, Andrew G. Polson, Bing Zheng, Xiaocheng Chen, Cecilia Pui Chi Chiu, Mark S. Dennis, Allen Ebens, Yan Wu
  • ANTI-B7-H4 ANTIBODIES AND IMMUNOCONJUGATES
    Publication number: 20160159910
    Abstract: The invention provides anti-B7-H4 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: September 11, 2015
    Publication date: June 9, 2016
    Applicant: GENENTECH, INC.
    Inventors: Steven R. Leong, Andrew Polson, Paul Polakis, Yan Wu, Wei-Ching Liang, Ron Firestein
  • Anti-VEGF antibodies
    Patent number: 9353177
    Abstract: Anti-VEGF antibodies and variants thereof, including those having high affinity for binding to VEGF, are disclosed. Also provided are methods of using phage display technology with naïve libraries to generate and select the anti-VEGF antibodies with desired binding and other biological activities. Further contemplated are uses of the antibodies in research, diagnostic and therapeutic applications.
    Type: Grant
    Filed: March 3, 2015
    Date of Patent: May 31, 2016
    Assignee: Genentech, Inc.
    Inventors: Germaine Fuh, Hans-Peter Gerber, Wei-Ching Liang, Frederic Fellouse, Sachdev S. Sidhu, Christian Wiesmann
  • ANTI-LGR5 ANTIBODIES AND IMMUNOCONJUGATES
    Publication number: 20160102146
    Abstract: The invention provides anti-LgR5 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: September 17, 2015
    Publication date: April 14, 2016
    Applicant: GENENTECH, INC.
    Inventors: Jo-Anne Hongo, Weiguang Mao, Paul Polakis, Andrew Polson, Rajesh Vij, Yan Wu, Wei-Ching Liang
  • ANTI-CLL-1 ANTIBODIES AND IMMUNOCONJUGATES
    Publication number: 20160075787
    Abstract: The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: September 11, 2015
    Publication date: March 17, 2016
    Applicant: GENENTECH, INC.
    Inventors: Bing Zheng, Andrew Polson, Cecilia Chiu, Wei-Ching Liang